5‐Amino‐4‐(4‐dimethylaminophenyl)‐2‐(4‐methoxyphenyl)‐7‐(pyrrolidin‐1‐yl)‐1,6‐naphthyridine‐8‐carbonitrile
暂无分享,去创建一个
[1] A. Fujishima,et al. Axially chiral 1,7-naphthyridine-6-carboxamide derivatives as orally active tachykinin NK(1) receptor antagonists: synthesis, antagonistic activity, and effects on bladder functions. , 1999, Journal of medicinal chemistry.
[2] C. Manera,et al. Synthesis and evaluation of antimycobacterial activity of 4-phenyl-1,8-naphthyridine derivatives. , 1998, Farmaco.
[3] M. Cg,et al. Electric field mapping and structure-activity relationship for cardiotonic activities of medorinone and some of its analogs. , 1997 .
[4] M. Nardelli,et al. PARST95 – an update to PARST: a system of Fortran routines for calculating molecular structure parameters from the results of crystal structure analyses , 1995 .
[5] R. Bentley,et al. Novel and potent adenosine 3',5'-cyclic phosphate phosphodiesterase III inhibitors: thiazolo[4,5-b][1,6]naphthyridin-2-ones. , 1995, Journal of medicinal chemistry.
[6] V. Masilamani,et al. A new class of laser dyes from the acridinedione derivatives , 1993 .
[7] M. Spedding,et al. The pharmacology of RS‐15385‐197, a potent and selective α2‐adrenoceptor antagonist , 1993 .
[8] D. Cremer,et al. General definition of ring puckering coordinates , 1975 .